The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 2,401–2,600 of 3,517
Stewart, J. W., Quitkin, F. M., McGrath, P. J., & Klein, D. F. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.01.009 · Cited by 72
Tryptophan depletion in SSRI-recovered depressed outpatients
Spillmann, M. K., van der Does, W. A. J., Rankin, M. A., Vuolo, R. D., Alpert, J. E., Nierenberg, A. A., Rosenbaum, J. F., Hayden, D., Schoenfeld, D., & D, M. F. M. (2001) · Psychopharmacology · doi:10.1007/s002130000669 · Cited by 72
GALANTAMINE: A REVIEW OF ITS USE IN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA
Corey, J. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10467.x · Cited by 72
Thanky, N. R., Son, J. H., & Herbison, A. E. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00383-2 · Cited by 71
Tachyphylaxis in unipolar major depressive disorder
Solomon, D. A., Leon, A. C., Mueller, T. I., Coryell, W., Teres, J. J., Posternak, M. A., Judd, L. L., Endicott, J., & Keller, M. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0302 · Cited by 71
Thase, M. E. (2004) · CNS Spectrums · doi:10.1017/s1092852900002236 · Cited by 71
Novel aspects of pain management : opioids and beyond
Sawynok, J. (1999) · Cited by 71
Reboxetine: Attenuation of Intravenous Nicotine Self-Administration in Rats
Rauhut, A. S., Mullins‐Sweatt, S. N., Dwoskin, L. P., & Bardo, M. T. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.303.2.664 · Cited by 71
Kogen, H., Toda, N., Tago, K., Marumoto, S., Takami, K., Ori, M., Yamada, N., Koyama, K., Naruto, S., Abe, K., et al. (2002) · Organic Letters · doi:10.1021/ol026418e · Cited by 71
Yamada, J., Saitow, F., Satake, S., Kiyohara, T., & Konishi, S. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00126-4 · Cited by 71
Denys, D. A. J. P., van Megen, H. J. G. M., & Westenberg, H. G. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0807 · Cited by 71
The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset
Smith, A. G., Neill, J. C., & Costall, B. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00230-5 · Cited by 71
Local GABAergic modulation of acetylcholine release from the cortex of freely moving rats
Giorgetti, M., Bacciottini, L., Giovannini, M. G., Colivicchi, M. A., Goldfarb, J., & Blandina, P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00079.x · Cited by 71
Hanoun, N., Mocaër, E., Boyer, P., Hamon, M., & Lanfumey, L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.003 · Cited by 71
Antidepressant Profile of Bupropion and three Metabolites in Mice
Martin, P., Massol, J., Colin, J. N., Lacomblez, L., & Puech, A. J. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014505 · Cited by 71
Spreng, M., Cotecchia, S., & Schenk, F. (2001) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2000.3965 · Cited by 71
Chau, D. T., Rada, P. V., Kosloff, R. A., Taylor, J. L., & Hoebel, B. G. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00133-6 · Cited by 71
Effects of sleep deprivation on extracellular serotonin in hippocampus and frontal cortex of the rat
Bjorvatn, B., Grønli, J., Hamre, F., Sørensen, E., Fiske, E., Bjørkum, A. A., Portas, C. M., & Ursin, R. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00181-1 · Cited by 71
Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors
Newman‐Tancredi, A., Audinot, V., Gobert, A., & Millan, M. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00985-5 · Cited by 71
Self-citationWu, J., George, A. A., Schroeder, K. M., Xu, L., Marxer-Miller, S., Lucero, L. M., & Lukas, R. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070417 · Cited by 71
Zis, A. P., Gg, N., Ee, B., Damsma, G., & Fibiger, H. (1992) · PubMed · Cited by 71
Cholecystokinin and panic disorder: Past and future clinical research strategies
Bradwejn, J., & Koszycki, D. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/713783681 · Cited by 71
(1996) · PubMed · Cited by 70
5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms.
Groenink, L., van Bogaert, M. J. V., van der Gugten, J., Oosting, R. S., & Olivier, B. (2003) · PubMed · doi:10.1097/01.fbp.0000087737.21047.75 · Cited by 70
Plasma levels of citalopram enantiomers and metabolites in elderly patients.
Foglia, J. P., Pollock, B. G., Kirshner, M. A., Rosen, J., Sweet, R. A., & Mulsant, B. H. (1997) · PubMed · Cited by 70
Lucki, I., & O'Leary, O. F. (2004) · PubMed · Cited by 70
D3 receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens
Zapata, A. G., & Shippenberg, T. S. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00893.x · Cited by 70
Cao, Y., Surowy, C. S., & Puttfarcken, P. S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.005 · Cited by 70
Buspirone Augmentation of Antidepressant Therapy
Dimitriou, E. C., & Dimitriou, C. E. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00009 · Cited by 70
Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory
Daniel, J. M., Hulst, J. L., & Lee, C. D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.002 · Cited by 70
Phosphodiesterase 5 enzyme and its inhibitors: Update on pharmacological and therapeutical aspects
Kulkarni, S. K., & Patil, C. S. (2004) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2004.26.10.872561 · Cited by 70
Female Sexual Dysfunction: Potential for Pharmacotherapy
Fourcroy, J. L. (2003) · Drugs · doi:10.2165/00003495-200363140-00002 · Cited by 70
Pérez, V., Puigdemont, D., Gilaberte, I., Álvarez, E., & Artigas, F. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00008 · Cited by 70
Deakin, J. F. W. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199112003-00002 · Cited by 70
Oshima, A., Flachskamm, C., Reul, J. M. H. M., Holsboer, F., & Linthorst, A. C. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300267 · Cited by 70
Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice
Perrault, G., Morel, É., Živković, B., & Sanger, D. J. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90444-k · Cited by 70
Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat
Dableh, L. J., Yashpal, K., Rochford, J. M., & Henry, J. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.11.024 · Cited by 70
Schlaepfer, T. E., Kosel, M., & Nemeroff, C. B. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300038 · Cited by 70
Malagié, I., Deslandes, A., & Gardier, A. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00486-6 · Cited by 70
Ryckmans, T., Balançon, L., Berton, O., Génicot, C., Lamberty, Y., Lallemand, B., Pasau, P., Pirlot, N., Quéré, L., & Talaga, P. E. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00727-2 · Cited by 70
Esteban, S., Lladó, J., Sastre-Coll, A., & García‐Sevilla, J. A. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900045 · Cited by 70
Neuroprotective effects of D3 dopamine receptor agonists
Carvey, P. M., McGuire, S. O., & Ling, Z. D. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00061-4 · Cited by 70
Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages
Bender, A. T., & Beavo, J. A. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.015 · Cited by 70
Whitton, P. S., Sarna, G. S., O’Connell, M. T., & Curzon, G. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90035-a · Cited by 70
Importance of NPY Y1 receptor-mediated pathways: assessment using NPY Y1 receptor knockouts
Pedrazzini, T. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.007 · Cited by 70
Pharmacology and Biology of Corticotropin-Releasing Factor (CRF) Receptors
Eckart, K., Jahn, O., Radulović, J., Radulović, M., Blank, T., Stiedl, O., Brauns, O., Tezval, H., Zeyda, T., & Spiess, J. (2002) · Receptors and Channels · doi:10.1080/10606820213678 · Cited by 70
Imbeaud, S., & Auffray, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03565-8 · Cited by 70
Arnsten, A. F. T., Murphy, B., & Merchant, K. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00133-0 · Cited by 70
Neuroendocrine profiles in mood disorders
Linkowski, P. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003407 · Cited by 70
V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze
Egashira, N., Tanoue, A., Higashihara, F., Mishima, K., Fukue, Y., Takano, Y., Tsujimoto, G., Iwasaki, K., & Fujiwara, M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.050 · Cited by 69
Extended-release venlafaxine in relapse prevention for patients with major depressive disorder
Simon, J. S., Aguiar, L. M., Kunz, N. R., & Lei, D. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.10.004 · Cited by 69
Treatment of Recurrent Depression: A Sequential Psychotherapeutic and Psychopharmacological Approach
Fava, G. A., Ruini, C., & Sonino, N. (2003) · CNS Drugs · doi:10.2165/00023210-200317150-00005 · Cited by 69
The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats
Torregrossa, M. M., Isgor, C., Folk, J. E., Rice, K. C., Watson, S. J., & Woods, J. H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300345 · Cited by 69
Localization of GABAB receptors in midbrain monoamine containing neurons in the rat
Wirtshafter, D., & Sheppard, A. C. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00487-7 · Cited by 69
A, T. R. D. J., Pattij, T., Veening, J. G., Waldinger, M. D., Cools, A. R., & Olivier, B. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2186-6 · Cited by 69
Neurosteroids and neuroactive drugs in mental disorders
Pisu, M. G., & Serra, M. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.12.002 · Cited by 69
Pinna, G., Costa, E., & Guidotti, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401479101 · Cited by 69
Mize, A. L., Poisner, A. M., & Alper, R. H. (2001) · Neuroendocrinology · doi:10.1159/000054633 · Cited by 69
Electroconvulsive therapy in depressive illness that has not responded to drug treatment
Husain, S. S., Kevan, I. M., Linnell, R., & Scott, A. I. F. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.05.006 · Cited by 69
Cholecystokinin and panic disorder: Past and future clinical research strategies
Bradwejn, D. K. J., & Koszycki, D. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/clb.61.234.19.27 · Cited by 69
Lamont, S. R., Paulls, A., & Stewart, C. A. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03287-x · Cited by 69
Grilli, M., Parodi, M., Raiteri, M., & Marchi, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03126.x · Cited by 68
Shibata, S., Tsuneyoshi, A., Hamada, T., Tominaga, K., & Watanabe, S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91482-t · Cited by 68
Raven, P., O’Dwyer, A.-M., Taylor, N., & Checkley, S. A. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00057-7 · Cited by 68
Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells
Chen, Y., Peng, L., Zhang, X., Stolzenburg, J., & Hertz, L. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00082-p · Cited by 68
Gobert, A., Rivet, J., Cistarelli, L., & Millan, M. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031326.x · Cited by 68
Self-citationBupropion-Sustained Release as a Treatment for SSRI-Induced Sexual Side Effects
Gitlin, M. J., Suri, R., Altshuler, L. L., Zuckerbrow-Miller, J., & Fairbanks, L. A. (2002) · Journal of Sex & Marital Therapy · doi:10.1080/00926230252851870 · Cited by 68
Regulation of the norepinephrine transporter by chronic administration of antidepressants
Benmansour, S., Altamirano, A. V., Jones, D. J., Sanchez, T. A., Gould, G. G., Pardon, M., Morilak, D. A., & Frazer, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00676-0 · Cited by 68
Sexual functioning in depressed outpatients taking mirtazapine
Boyarsky, B. K., Haque, W., Rouleau, M. R., & Hirschfeld, R. M. A. (1999) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1999)9:4<175::aid-da5>3.0.co;2-0 · Cited by 68
Total sleep deprivation increases extracellular serotonin in the rat hippocampus
Lopez-Rodriguez, F., Wilson, C. L., Maidment, N. T., Poland, R. E., & Engel, J. D. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00335-x · Cited by 68
Multiple 5-HT1 autoreceptor subtypes govern serotonin release in dorsal and median raphé nuclei
Hopwood, S. E., & Stamford, J. A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00192-1 · Cited by 68
Mechanisms of Cross-Talk between G-Protein-Coupled Receptors
Cordeaux, Y., & Hill, S. J. (2002) · Neurosignals · doi:10.1159/000057321 · Cited by 68
Phenylethylamine, a possible link to the antidepressant effects of exercise?: Figure 1
Szabó, A., Billett, E. E., & Turner, J. (2001) · British Journal of Sports Medicine · doi:10.1136/bjsm.35.5.342 · Cited by 68
Breitinger, H., Geetha, N., & Hess, G. P. (2001) · Biochemistry · doi:10.1021/bi0106890 · Cited by 68
Baker, G. B., & Prior, T. I. (2002) · Annals of Medicine · doi:10.1080/078538902321117742 · Cited by 68
Current review of the comorbidity of affective, anxiety, and substance use disorders
Myrick, H., & Brady, K. (2003) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000069080.26384.d8 · Cited by 68
Clinical experience with substance P receptor (NK1) antagonists in depression.
Ranga, K., & Krishnan, R. (2002) · PubMed · Cited by 68
Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice.
Volke, V., Wegener, G., & Vasar, E. (2003) · PubMed · Cited by 67
Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat
Aguilera, G., & Rabadan‐Diehl, C. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00004.x · Cited by 67
(2004) · PubMed · Cited by 67
Kocabas, A., Rudnick, G., & Kilic, F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01793.x · Cited by 67
Rapid Desensitization of the Serotonin2C Receptor System: Effector Pathway and Agonist Dependence
Stout, B. D., Clarke, W. P., & Berg, K. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.3.957 · Cited by 67
Pratt, G. D., & Bowery, N. G. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13872.x · Cited by 67
The role of 5ht2c receptors in affective disorders
Jenck, F., Bös, M., Wichmann, J., Stadler, H., Martin, J. R., & Moreau, J. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.10.1587 · Cited by 67
Egawa, T., Mishima, K., Matsumoto, Y., Iwasaki, K., Iwasaki, K., & Fujiwara, M. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.75.275 · Cited by 67
Roberts, C., Thomas, D. R., Bate, S. T., & Kew, J. N. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.010 · Cited by 67
Felton, T. M., Kang, T. B., Hjorth, S., & Auerbach, S. B. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0688-x · Cited by 67
Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies
Mylecharane, E. J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00061-7 · Cited by 67
Signal transduction abnormalities in melancholic depression
Akın, D., Manier, D. H., Sanders‐Bush, E., & Shelton, R. C. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570400478x · Cited by 67
Effects of melatonin receptor ligands on swim test immobility
Overstreet, D. H., Puciłowski, O., Retton, M.-C., Delagrange, P., & Lemaître, B. J. (1998) · Neuroreport · doi:10.1097/00001756-199801260-00014 · Cited by 67
Posternak, M. A., & Zimmerman, M. A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0605 · Cited by 67
Ferraro, L., Fuxé, K., Tanganelli, S., Tomasini, M. C., Rambert, F. A., & Antonelli, T. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10196 · Cited by 67
Waldinger, M. D., Zwinderman, A. H., & Olivier, B. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000088904.24613.e4 · Cited by 67
Adaptive walks in a gene network model of morphogenesis: insights into the Cambrian explosion
Solé, R. V., Fernández, P., & Kauffman, S. A. (2003) · The International Journal of Developmental Biology · doi:10.1387/ijdb.14756344 · Cited by 67
McPherson, S., Cairns, P., Carlyle, J., Shapiro, D. A., Richardson, P., & Taylor, D. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00498.x · Cited by 66
Clinical pharmacology of bupropion and imipramine in elderly depressives.
Branconnier, R. J., Cole, J. O., Ghazvinian, S., Spera, K. F., Oxenkrug, G. F., & Bass, J. L. (1983) · PubMed · Cited by 66
The evolving definition of treatment resistance.
Peuskens, J. (1999) · PubMed · Cited by 66
Modafinil and cortical γ-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins
Tanganelli, S., de la Mora, M. P., Ferraro, L., Méndez-Franco, J., Beani, L., Rambert, F. A., & Fuxé, K. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00675-w · Cited by 66
Microarray analysis of rat brain gene expression after chronic administration of sodium valproate
Bosetti, F., Bell, J. M., & Manickam, P. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.01.004 · Cited by 66
D’Aquila, P. S., Collu, M., Pani, L., Gessa, G. L., & Serra, G. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90033-7 · Cited by 66
Dziewczapolski, G., Menalled, L., García, M. C., Mora, M. A., Gershanik, O. S., & Rubinstein, M. (1998) · Neuroreport · doi:10.1097/00001756-199801050-00001 · Cited by 66
Moreau, J., Jenck, F., Martin, J. R., Perrin, S., & Haefely, W. E. (1993) · Psychopharmacology · doi:10.1007/bf02246963 · Cited by 66
Herring, D., Huang, R., Singh, M., Dillon, G. H., & Leidenheimer, N. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.015 · Cited by 66
Obesity and depression: same disease, different names?
Rosmond, R. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.030 · Cited by 66
Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors
Kawashima, N., Karasawa, J.-I., Shimazaki, T., Chaki, S., Okuyama, S., Yasuhara, A., & Nakazato, A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.021 · Cited by 66
Fossati, P., Ergis, A.-M., & Allilaire, J. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00307-9 · Cited by 66
Holschneider, D. P., Chen, K., Seif, I., & Shih, J. C. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00613-x · Cited by 66
Time course of clinical response to venlafaxine: relevance of plasma level and chirality
Gex‐Fabry, M., Balant-Gorgia, A. E., Balant, L. P., Rudaz, S. L., Veuthey, J., & Bertschy, G. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0710-3 · Cited by 66
Evidence that 5‐HT2receptor activation decreases noradrenaline release in rat hippocampusin vivo
Done, C., & Sharp, T. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14493.x · Cited by 66
Systematic review of antidepressant therapies in Parkinson's disease.
Chung, T. H., Deane, K. H. O., Ghazi-Noori, S., Rickards, H., & Clarke, C. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(03)00108-1 · Cited by 66
Perspectives on cognitive domains, H3receptor ligands and neurological disease
Hancock, A. A., & Fox, G. B. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.10.1237 · Cited by 66
Raiteri, L., Raiteri, M., & Bonanno, G. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00059-x · Cited by 66
Managing treatment-resistant major depression.
Nelson, J. C. (2003) · PubMed · Cited by 66
Guiard, B. P., Przybylski, C., Guilloux, J., Seif, I., Froger, N., Felipe, C. D., Hunt, S. P., Lanfumey, L., & Gardier, A. M. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02304.x · Cited by 66
von Frijtag, J. C., Kamal, A., Reijmers, L. G. J. E., Schrama, L. H., van den Bos, R., & Spruijt, B. M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02062-6 · Cited by 66
Neumeister, A., Praschak-Rieder, N., Heßelmann, B., Vitouch, O., Rauh, M., Barocka, A., Tauscher, J. T., & Kasper, S. F. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.167 · Cited by 66
Millan, M. J., Lejeune, F., Nanteuil, G. D., & Gobert, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00211.x · Cited by 65
Self-citationSerrats, J., Artigas, F., Mengod, G., & Cortés, R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01557.x · Cited by 65
Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression
Mallinckrodt, C. H., GOLDSTEIN, D. J., Detke, M. J., Lu, Y., & Trân, P. V. (2003) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v05n0105 · Cited by 65
Agonist and Antagonist Actions of (-)Pindolol at Recombinant, Human Serotonin1A (5-HT1A) Receptors
Newman‐Tancredi, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00169-3 · Cited by 65
Melanin concentrating hormone (MCH): A novel neural pathway for regulation of GnRH neurons
Williamson-Hughes, P. S., Grove, K. L., & Smith, M. S. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.066 · Cited by 65
O‘Neill, M. F., Fernández, A. G., & Palacios, J. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02047-0 · Cited by 65
Fan, P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13140.x · Cited by 65
Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression
Izumi, T., Inoue, T., Kitagawa, N., Nishi, N., Shimanaka, S., Takahashi, Y., Kusumi, I., Odagaki, Y., Denda, K., Ohmori, T., et al. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00199-8 · Cited by 65
Endogenous biochemical abnormalities in affective illness: Therapeutic versus pathogenic
Post, R. M., & Weiss, S. R. B. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90216-m · Cited by 65
Combinations of Neurokinin Receptor Antagonists Reduce Visceral Hyperalgesia
Kamp, E. H., Beck, D. R., & Gebhart, G. F. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29307-1 · Cited by 65
Avissar, S., Ruban, A., Tzukert, K., & Schreiber, G. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2066 · Cited by 65
Serotonin receptor ligands and the treatment of obesity.
Vickers, S. P., & Dourish, C. T. (2004) · PubMed · Cited by 64
MT1 melatonin receptor mRNA tissular localization by PCR amplification.
Poirel, V., Cailotto, C., Streicher, D., Pévet, P., Masson‐Pévet, M., & Gauer, F. (2003) · PubMed · Cited by 64
Haddjeri, N., Blier, P., & de Montigny, C. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00223-7 · Cited by 64
Aging alters feedback effects of the activity-rest cycle on the circadian clock
Reeth, O. V., Zhang, Y., Zee, P. C., & Turek, F. W. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.263.4.r981 · Cited by 64
Ashina, S., Bendtsen, L., & Jensen, R. (2004) · Pain · doi:10.1016/j.pain.2003.12.012 · Cited by 64
Mirza, N. R., Bright, J., Stanhope, K. J., Wyatt, A. C., & Harrington, N. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2146-1 · Cited by 64
Iosifescu, D. V., Nierenberg, A. A., Mischoulon, D., Perlis, R. H., Papakostas, G. I., Ryan, J. L., Ryan, J. L., Alpert, J. E., & D, M. F. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0812 · Cited by 64
Kästner, A., Hirsch, É. C., Herrero, M. T., Javoy-Agid, F., & Agid, Y. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03616.x · Cited by 64
Aragona, M., Bancheri, L., Perinelli, D., Tarsitani, L., Pizzimenti, A., Conte, A., & Inghilleri, M. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2004.03.003 · Cited by 64
Zimmerman, M. A., Posternak, M. A., & Chelminski, I. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155824.59585.46 · Cited by 64
Szabo, S. T. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00284-6 · Cited by 64
Serretti, A., & Artioli, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1822-x · Cited by 64
Parker, L. L., Backstrom, J. R., Sanders‐Bush, E., & Shieh, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210973200 · Cited by 64
GABA receptors and benzodiazepine binding sites modulate hippocampal acetylcholine release in vivo
Moor, E., DeBoer, P., & Westerink, B. H. C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00642-6 · Cited by 64
Future Antidepressants: What is in the Pipeline and What is Missing?
Bosker, F. J., Westerink, B. H. C., Cremers, T. I. F. H., Gerrits, M., van der Hart, M. G. C., Kuipers, S. D., van der Pompe, G., Horst, G. J. T., den Boer, J. A., & Korf, J. (2004) · CNS Drugs · doi:10.2165/00023210-200418110-00002 · Cited by 64
Gordon, J. T., Kaminski, D. M., Rozanov, C., & Dratman, M. B. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00146-3 · Cited by 64
Wu, J. C., Buchsbaum, M. S., & Bunney, W. E. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00336-0 · Cited by 64
Cost of affective disorders in Europe
Andlin‐Sobocki, P., & Wïttchen, H. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01195.x · Cited by 64
Rodríguez–Manzo, G., & Fernández‐Guasti, A. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02007-e · Cited by 64
Pan, W. H. T., Yang, S., & Lin, S. (2004) · Synapse · doi:10.1002/syn.20034 · Cited by 64
Null Mutations Lacking Substance: Elucidating Pain Mechanisms by Genetic Pharmacology
Woolf, C. J., Mannion, R., & Neumann, S. (1998) · Neuron · doi:10.1016/s0896-6273(00)80487-0 · Cited by 63
Zocchi, A., Varnier, G., Arban, R., Griffante, C., Zanetti, L., Bettelini, L., Marchi, M., Gerrard, P. A., & Corsi, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00305-7 · Cited by 63
Koch, S., Perry, K. W., & Bymaster, F. P. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.001 · Cited by 63
Cryan, J. F., McGrath, C., Leonard, B. E., & Norman, T. R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00402-6 · Cited by 63
Nicotinic Cholinergic Modulation: Galantamine as a Prototype
Woodruff‐Pak, D. S., Lander, C., & Geerts, H. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00237.x · Cited by 63
Substance dependence as a compulsive behavior
Koob, G. F., Rocio, M., Carrera, A. B., Gold, L. H., Heyser, C. J., Maldonado-Irizarry, C. S., Markou, A., Parsons, L. H., Roberts, A. J., Schulteis, G., et al. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200106 · Cited by 63
Zajecka, J., Dünner, D. L., Gelenberg, A. J., Hirschfeld, R. M. A., Kornstein, S. G., Ninan, P. T., Rush, A. J., Thase, M. E., Trivedi, M. H., Arnow, B. A., et al. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0809 · Cited by 63
Circadian rhythm abnormalities of deep body temperature in depressive disorders
Daimon, K., Yamada, N., Tsujimoto, T., & Takahashi, S. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90015-x · Cited by 63
Wang, S., Su, C., & Kuo, Y. (2003) · Synapse · doi:10.1002/syn.10200 · Cited by 63
Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors
Gitlin, M. J., Altshuler, L. L., Frye, M. A., Suri, R., Huynh, E. L., Fairbanks, L. A., Bauer, M., & Korenman, S. G. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0437 · Cited by 63
Ensaculin (KA‐672. HCl): A Multitransmitter Approach to Dementia Treatment
Hoerr, R., & Noeldner, M. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00220.x · Cited by 63
Mechanism of Corticotropin-Releasing Factor Type I Receptor Regulation by Nonpeptide Antagonists
Hoare, S. R. J., Sullivan, S., LING, N. C., Crowe, P. D., & Grigoriadis, D. E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.751 · Cited by 63
Knobelman, D. A., Hen, R., Blendy, J. A., & Lucki, I. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29478-7 · Cited by 63
Mice Lacking PKCγ Exhibit Decreased Anxiety
Bowers, B. J., Collins, A. C., Tritto, T., & Wehner, J. M. (2000) · Behavior Genetics · doi:10.1023/a:1001951104208 · Cited by 62
Cappelli, A., Gallelli, A., Manini, M., Anzini, M., Mennuni, L., Makovec, F., Menziani, M. C., Alcaro, S., Ortuso, F., & Vomero, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493461 · Cited by 62
Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder
Appelhof, B. C., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Huyser, J., Schene, A. H., Tijssen, J. G. P., & Wiersinga, W. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1147 · Cited by 62
Pitsikas, N., Rigamonti, A. E., Cella, S. G., & Müller, E. E. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03091-9 · Cited by 62
Davidson, C., & Stamford, J. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11390-i · Cited by 62
Reboxetine: Functional Inhibition of Monoamine Transporters and Nicotinic Acetylcholine Receptors
Miller, D. K., Wong, E. H. F., Chesnut, M. D., & Dwoskin, L. P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.2.687 · Cited by 62
Tokuda, M., & Hatase, O. (1998) · Molecular Neurobiology · doi:10.1007/bf02802028 · Cited by 62
Combined effects of diazepam and melatonin in two tests for anxiolytic activity in the mouse
Lemaître, B. J., Lenègre, A., & Porsolt, R. D. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90118-y · Cited by 62
The MCH receptor family: feeding brain disorders?
Forray, C. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00013-9 · Cited by 62
Griebel, G., Perrault, G., & Soubrié, P. (2001) · Psychopharmacology · doi:10.1007/s002130100830 · Cited by 62
Dornan, W. A., & Malsbury, C. W. (1989) · Physiology & Behavior · doi:10.1016/0031-9384(89)90034-6 · Cited by 62
New approaches to developing antidepressants by enhancing monoaminergic neurotransmission
Bymaster, F. P., McNamara, R. K., & Trân, P. V. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.531 · Cited by 62
Phosphorylation and Regulation of Psychostimulant-Sensitive Neurotransmitter Transporters
Vaughan, R. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052423 · Cited by 62
Bright light therapy for winter depression-is phase advancing beneficial?
Burgess, H. J., Fogg, L. F., Young, M. A., & Eastman, C. I. (2004) · Chronobiology International · doi:10.1081/cbi-200025979 · Cited by 61
D2 receptors in the paraventricular nucleus regulate genital responses and copulation in male rats
Eaton, R. C., Markowski, V. P., Lumley, L. A., Thompson, J. T., Moses, J., & Hull, E. M. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90418-2 · Cited by 61
Neurotransmitter Changes by Interferon-Alpha and Therapeutic Implications
Schaefer, M., Schwaiger, M., Pich, M. G. L., Lieb, K., & Heinz, A. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45131 · Cited by 61
Wegener, G., Bandpey, Z., Heiberg, I. L., Mørk, A., & Rosenberg, R. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1341-6 · Cited by 61
Nowak, G., Legutko, B., Skolnick, P., & Popik, P. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01589-6 · Cited by 61
Weinstock, M., Poltyrev, T., Bejar, C., & Youdim, M. B. H. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0978-x · Cited by 61
Kántor, S., Jakus, R., Balogh, B., Benkő, A., & Bagdy, G. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705887 · Cited by 61
Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder
Anand, A., Darnell, A., Miller, H., Berman, R., Cappiello, A., Oren, D. A., Woods, S. W., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00293-5 · Cited by 61
Lelong‐Boulouard, V., Lhonneur, L., Dauphin, F., & Boulouard, M. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0743-2 · Cited by 61
The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression
Sulser, F. (2002) · Annals of Medicine · doi:10.1080/078538902320772106 · Cited by 61
The Receptor Concept: A Continuing Evolution
Limbird, L. E. (2004) · Molecular Interventions · doi:10.1124/mi.4.6.6 · Cited by 61
Orsetti, M., Dellarole, A., Ferri, S., & Ghi, P. (2003) · Learning & Memory · doi:10.1101/lm.67303 · Cited by 61
Rational drug discovery: what can we learn from regulatory networks?
Huang, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02463-7 · Cited by 61
Butler, M. O., Morinobu, S., & Duman, R. S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13618.x · Cited by 61
Li, J., McRoberts, J. A., Nie, J., Ennes, H. S., & Mayer, E. A. (2004) · Pain · doi:10.1016/s0304-3959(04)00101-0 · Cited by 61
Distribution of preprovasopressin mRNA in the rat central nervous system
Hallbeck, M., Hermanson, O., & Blomqvist, A. G. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990823)411:2<181::aid-cne2>3.0.co;2-1 · Cited by 61
What can neuroimaging findings tell us about sleep disorders?
Nofzinger, E. A. (2004) · Sleep Medicine · doi:10.1016/s1389-9457(04)90003-2 · Cited by 61
Reynolds, J. L., Ignatowski, T. A., Sud, R., & Spengler, R. N. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067835 · Cited by 61
Kreiss, D. S., & Lucki, I. (1997) · Synapse · Cited by 61
Origin of New Genes: Evidence from Experimental and Computational Analyses
Long, M., Deutsch, M., Wang, W., Betrán, E., Brunet, F., & Zhang, J. (2003) · Genetica · doi:10.1023/a:1024153609285 · Cited by 61
Long-term side effects of SSRIs: sexual dysfunction and weight gain.
Hirschfeld, R. M. A. (2003) · PubMed · Cited by 60
Treatment of antidepressant nonresponders: augmentation or switch?
Nelson, J. C. (1998) · PubMed · Cited by 60
Gobert, A., Cara, B. D., Cistarelli, L., & Millan, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046383 · Cited by 60
Self-citationMundo, E., Maina, G., & Uslenghi, C. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015020-00002 · Cited by 60
Baumgartner, A. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001887 · Cited by 60
Ellis, C., Monk, C., Simmons, A., Lemmens, G. M. D., Williams, S., Brammer, M. J., Bullmore, E. T., & Parkes, J. D. (1999) · Journal of Sleep Research · doi:10.1046/j.1365-2869.1999.00142.x · Cited by 60
Effects of Trazodone and Fluoxetine in the Treatment of Major Depression
Maes, M. H. J., Westenberg, H. G. M., Vandoolaeghe, E., Demedts, P., Wauters, A., Neels, H. M., & Meltzer, H. Y. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199710000-00004 · Cited by 60
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.